000121194 001__ 121194 000121194 005__ 20240319081019.0 000121194 0247_ $$2doi$$a10.3390/nu14224758 000121194 0248_ $$2sideral$$a131791 000121194 037__ $$aART-2022-131791 000121194 041__ $$aeng 000121194 100__ $$aGómez-Sánchez, Leticia 000121194 245__ $$aLong-Term Effectiveness of a Smartphone App and a Smart Band on Arterial Stiffness and Central Hemodynamic Parameters in a Population with Overweight and Obesity (Evident 3 Study): Randomised Controlled Trial 000121194 260__ $$c2022 000121194 5060_ $$aAccess copy available to the general public$$fUnrestricted 000121194 5203_ $$aBackground: mHealth technologies could help to improve cardiovascular health; however, their effect on arterial stiffness and hemodynamic parameters has not been explored to date. Objective: To evaluate the effect of a mHealth intervention, at 3 and 12 months, on arterial stiffness and central hemodynamic parameters in a sedentary population with overweight and obesity. Methods: Randomised controlled clinical trial (Evident 3 study). 253 subjects were included: 127 in the intervention group (IG) and 126 in the control group (CG). The IG subjects were briefed on the use of the Evident 3 app and a smart band (Mi Band 2, Xiaomi) for 3 months to promote healthy lifestyles. All measurements were recorded in the baseline visit and at 3 and 12 months. The carotid-femoral pulse wave velocity (cfPWV) and the central hemodynamic parameters were measured using a SphigmoCor System® device, whereas the brachial-ankle pulse wave velocity (baPWV) and the Cardio Ankle Vascular Index (CAVI) were measured using a VaSera VS-2000® device. Results: Of the 253 subjects who attended the initial visit, 237 (93.7%) completed the visit at 3 months of the intervention, and 217 (85.3%) completed the visit at 12 months of the intervention. At 12 months, IG showed a decrease in peripheral augmentation index (PAIx) (−3.60; 95% CI −7.22 to −0.00) and ejection duration (ED) (−0.82; 95% CI −1.36 to −0.27), and an increase in subendocardial viability ratio (SEVR) (5.31; 95% CI 1.18 to 9.44). In CG, cfPWV decreased at 3 months (−0.28 m/s; 95% CI −0.54 to −0.02) and at 12 months (−0.30 m/s, 95% CI −0.54 to −0.05), central diastolic pressure (cDBP) decreased at 12 months (−1.64 mm/Hg; 95% CI −3.19 to −0.10). When comparing the groups we found no differences between any variables analyzed. Conclusions: In sedentary adults with overweight or obesity, the multicomponent intervention (Smartphone app and an activity-tracking band) for 3 months did not modify arterial stiffness or the central hemodynamic parameters, with respect to the control group. However, at 12 months, CG presented a decrease of cfPWV and cDBP, whereas IG showed a decrease of PAIx and ED and an increase of SEVR. 000121194 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/PI16-00101$$9info:eu-repo/grantAgreement/ES/ISCIII/PI16-00170$$9info:eu-repo/grantAgreement/ES/ISCIII/PI16-00421$$9info:eu-repo/grantAgreement/ES/ISCIII/PI16-00659$$9info:eu-repo/grantAgreement/ES/ISCIII/PI16-00765$$9info:eu-repo/grantAgreement/ES/ISCIII-RICAPPS/RD21-0016-0005$$9info:eu-repo/grantAgreement/ES/ISCIII-RICAPPS/RD21-0016-0009$$9info:eu-repo/grantAgreement/ES/ISCIII-RICAPPS/RD21-0016-0010$$9info:eu-repo/grantAgreement/ES/ISCIII-RICAPPS/RD21-0016-0025$$9info:eu-repo/grantAgreement/ES/MICINN-ISCIII-ERDF-ESF/FI17-00040-Investing in your future$$9info:eu-repo/grantAgreement/ES/MICINN-ISCIII-ERDF-ESF/PI16-00952-Investing in your future 000121194 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/ 000121194 590__ $$a5.9$$b2022 000121194 592__ $$a1.291$$b2022 000121194 591__ $$aNUTRITION & DIETETICS$$b17 / 87 = 0.195$$c2022$$dQ1$$eT1 000121194 593__ $$aNutrition and Dietetics$$c2022$$dQ1 000121194 593__ $$aFood Science$$c2022$$dQ1 000121194 594__ $$a9.0$$b2022 000121194 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000121194 700__ $$aGómez-Sánchez, Marta 000121194 700__ $$aLugones-Sánchez, Cristina 000121194 700__ $$aRodríguez-Sánchez, Emiliano 000121194 700__ $$aTamayo-Morales, Olaya 000121194 700__ $$aGonzalez-Sánchez, Susana 000121194 700__ $$0(orcid)0000-0002-5494-6550$$aMagallón-Botaya, Rosa$$uUniversidad de Zaragoza 000121194 700__ $$aRamirez-Manent, Jose Ignacio 000121194 700__ $$aRecio-Rodriguez, Jose I. 000121194 700__ $$aAgudo-Conde, Cristina 000121194 700__ $$aGarcía-Ortiz, Luis 000121194 700__ $$aGómez-Marcos, Manuel A. 000121194 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina 000121194 773__ $$g14, 22 (2022), 4758 [20 pp.]$$pNutrients$$tNutrients$$x2072-6643 000121194 8564_ $$s733974$$uhttps://zaguan.unizar.es/record/121194/files/texto_completo.pdf$$yVersión publicada 000121194 8564_ $$s3021077$$uhttps://zaguan.unizar.es/record/121194/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000121194 909CO $$ooai:zaguan.unizar.es:121194$$particulos$$pdriver 000121194 951__ $$a2024-03-18-15:59:31 000121194 980__ $$aARTICLE